Spero Therapeutics's total assets for Q3 2025 were $54.17M, a decrease of -12.80% from the previous quarter. SPRO total liabilities were $27.68M for the fiscal quarter, a -5.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.